{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:59:18Z","timestamp":1781909958216,"version":"3.54.5"},"reference-count":31,"publisher":"Manuscript Technomedia LLP","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Phcog Res"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/0974-8490.199774","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T09:13:33Z","timestamp":1486545213000},"page":"12","source":"Crossref","is-referenced-by-count":75,"title":["The Influence of pluronic F68 and F127 nanocarrier on physicochemical properties, in vitro release, and antiproliferative activity of thymoquinone drug"],"prefix":"10.5530","volume":"9","author":[{"given":"NoorHaida","family":"Mohd Kaus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Shaarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShahrulSahul","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3478","reference":[{"key":"key-10.4103\/0974-8490.199774-1","first-page":"233","volume-title":"Rapid preparation process of antiparkinsonian drug Mucuna pruriens silver nanoparticle by bioreduction and their characterization","author":"Arulkumar","year":"2010","journal-title":"Pharmacognosy Res"},{"key":"key-10.4103\/0974-8490.199774-2","first-page":"66","volume-title":"Liposome application: Problems and prospects","author":"Barenholz","year":"2001","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"key-10.4103\/0974-8490.199774-3","first-page":"1451","volume-title":"PEGylation, successful approach to drug delivery","author":"Veronese","year":"2005","journal-title":"Drug Discov Today"},{"key":"key-10.4103\/0974-8490.199774-4","first-page":"2928","volume-title":"A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer","author":"Chandran","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key-10.4103\/0974-8490.199774-5","first-page":"1432","volume-title":"Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly (ethylene glycol) via click chemistry","author":"Gopin","year":"2006","journal-title":"Bioconjug Chem"},{"key":"key-10.4103\/0974-8490.199774-6","first-page":"473","volume-title":"Polymersomes for drug delivery: Design, formation and characterization","author":"Lee","year":"2012","journal-title":"J Control Release"},{"key":"key-10.4103\/0974-8490.199774-7","first-page":"1600","volume-title":"Biodegradable long-circulating polymeric nanospheres","author":"Gref","year":"1994","journal-title":"Science"},{"key":"key-10.4103\/0974-8490.199774-8","first-page":"77","volume-title":"Multifunctional polymeric micelles for delivery of drugs and siRNA","author":"Jhaveri","year":"2014","journal-title":"Front Pharmacol"},{"key":"key-10.4103\/0974-8490.199774-9","first-page":"2863","volume-title":"Hydrogels for osteochondral repair based on photocrosslinkable carbamate dendrimers","author":"Degoricija","year":"2008","journal-title":"Biomacromolecules"},{"key":"key-10.4103\/0974-8490.199774-10","first-page":"378","volume-title":"A novel multifunctional poly (amidoamine) dendrimeric delivery system with superior encapsulation capacity for targeted delivery of the chemotherapy drug 10-hydroxycamptothecin","author":"Kong","year":"2014","journal-title":"Int J Pharm"},{"key":"key-10.4103\/0974-8490.199774-11","first-page":"11913","volume-title":"Dendrimer-encapsulated camptothecins: Increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro","author":"Morgan","year":"2006","journal-title":"Cancer Res"},{"key":"key-10.4103\/0974-8490.199774-12","first-page":"654","volume-title":"Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice","author":"Schluep","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"key-10.4103\/0974-8490.199774-13","first-page":"323","volume-title":"Polymersomes","author":"Discher","year":"2006","journal-title":"Annu Rev Biomed Eng"},{"key":"key-10.4103\/0974-8490.199774-14","first-page":"40","volume-title":"A review of the pharmaco-therapeutic effects of Nigella sativa","author":"Muhammad","year":"2002","journal-title":"J Med Res"},{"key":"key-10.4103\/0974-8490.199774-15","first-page":"299","volume-title":"Effects of Nigella sativa oil on gastric secretion and ethanol induced ulcer in rats","author":"El-Dakhakhny","year":"2000","journal-title":"J Ethnopharmacol"},{"key":"key-10.4103\/0974-8490.199774-16","first-page":"1640","volume-title":"Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential","author":"Ravindran","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0974-8490.199774-17","first-page":"141","volume-title":"Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-\u03baB signaling and IL-8 expression","author":"Ashour","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"key-10.4103\/0974-8490.199774-18","first-page":"18","volume-title":"Thymoquinone: Fifty years of success in the battle against cancer models","author":"Schneider-Stock","year":"2014","journal-title":"Drug Discov Today"},{"key":"key-10.4103\/0974-8490.199774-19","first-page":"822","volume-title":"Nanocarrier based formulation of Thymoquinone improves oral delivery: Stability assessment, in vitro and in vivo studies","author":"Singh","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"key-10.4103\/0974-8490.199774-20","first-page":"371","volume-title":"Thymoquinone in liposomes: A study of loading efficiency and biological activity towards breast cancer","author":"Odeh","year":"2012","journal-title":"Drug Deliv"},{"key":"key-10.4103\/0974-8490.199774-21","first-page":"2163","volume-title":"Thymoquinone-loaded nanostructured lipid carriers: Preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration","author":"Abdelwahab","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"key-10.4103\/0974-8490.199774-22","first-page":"5702","volume-title":"Synthesis and characterization of PHV-block-mPEG diblock copolymer and its formation of amphiphilic nanoparticles for drug delivery","author":"Shah","year":"2011","journal-title":"J Nanosci Nanotechnol"},{"key":"key-10.4103\/0974-8490.199774-23","first-page":"5705","volume-title":"Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: A pharmacoscintigraphic study","author":"Alam","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"key-10.4103\/0974-8490.199774-24","first-page":"771","volume-title":"Nanoparticle therapeutics: An emerging treatment modality for cancer","author":"Davis","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"key-10.4103\/0974-8490.199774-25","first-page":"5925","volume-title":"Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light","author":"Salmani","year":"2014","journal-title":"Molecules"},{"key":"key-10.4103\/0974-8490.199774-26","first-page":"1249","volume-title":"Thymoquinone: A promising anti-cancer drug from natural sources","author":"Gali-Muhtasib","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"key-10.4103\/0974-8490.199774-27","first-page":"91","volume-title":"PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a","author":"Bhattacharya","year":"2015","journal-title":"Biomaterials"},{"key":"key-10.4103\/0974-8490.199774-28","unstructured":"Zeta Potential: An Introduction in 30 Minutes. Available from: http:\/\/ www.malvern.com\/en\/support\/resource-center\/technical-notes\/ TN101104ZetaPotentialIntroduction.aspx. [Last accessed on 2005 Apr 07]."},{"key":"key-10.4103\/0974-8490.199774-29","first-page":"222","volume-title":"PEG-lipid micelles as drug carriers: Physiochemical attributes, formulation principles and biological implication","author":"Gill","year":"2015","journal-title":"J Drug Target"},{"key":"key-10.4103\/0974-8490.199774-30","first-page":"121","volume-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","author":"Huang","year":"2001","journal-title":"J Control Release"},{"key":"key-10.4103\/0974-8490.199774-31","first-page":"47","volume-title":"In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate","author":"El-Kamel","year":"2002","journal-title":"Int J Pharm"}],"container-title":["Pharmacognosy Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T09:39:24Z","timestamp":1769593164000},"score":1,"resource":{"primary":{"URL":"https:\/\/phcogres.com\/article\/9\/1\/12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["199774"],"URL":"https:\/\/doi.org\/10.4103\/0974-8490.199774","relation":{},"ISSN":["0974-8490"],"issn-type":[{"value":"0974-8490","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}